Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
2.08%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 10.64Close
$ 5.9 - $ 18.13 52-Week Range
Ticker Information
Ticker
NPCECompany Name
NEUROPACE INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQNEUROPACE INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
NPCE - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 1.84M | 2.08% | $ 88.57M |
| 3/31/2025 | $ 1.81M | 2.14% | $ 84.31M |
| 12/31/2024 | $ 1.77M | 2.21% | $ 79.91M |
| 9/30/2024 | $ 1.73M | 2.26% | $ 76.45M |
| 6/30/2024 | $ 1.67M | 2.33% | $ 71.82M |
| 3/31/2024 | $ 1.63M | 2.36% | $ 69.07M |
| 12/31/2023 | $ 1.6M | 2.45% | $ 65.42M |
| 9/30/2023 | $ 1.95M | 3.24% | $ 60.2M |
| 6/30/2023 | $ 2.29M | 4.17% | $ 54.93M |
| 3/31/2023 | $ 2.63M | 5.41% | $ 48.62M |
Key Performance Insights, Last 5 Years
- NEUROPACE INC's latest trailing twelve months (TTM) DepAmor % stands at 0.76%.
- Over the past 5 years, NEUROPACE INC's average DepAmor % has been 2.99%.
- The median DepAmor % for NEUROPACE INC during this period was 2.35%
- NEUROPACE INC reached its highest DepAmor % over the past 5 years at 6.56%.
- The lowest DepAmor % recorded by NEUROPACE INC in the same timeframe 0.66%
NEUROPACE INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for NEUROPACE INC is calculated as follows: DepAmor [ $ 312K ] / Revenues [ $ 41.14M ]
(=) DepAmor % [ 0.76% ] NPCE - Depreciation and Amortization Margin, Last 5 years
0.66%
Minimum
Dec 31, 2021
6.56%
Maximum
Dec 31, 2022
2.99%
Average
2.35%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.13%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.32K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.2% |
| std | 5.13% |